Alzheimer's Disease Diagnostic Market - Global Professional Analysis and Forecast to 2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The worldwide Alzheimer's Disease Diagnostic market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 8.5% during the forecast period.

    This report presents the market size and development trends by detailing the Alzheimer's Disease Diagnostic market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Alzheimer's Disease Diagnostic market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Alzheimer's Disease Diagnostic industry and will help you to build a panoramic view of the industrial development.

    Alzheimer's Disease Diagnostic Market, By Type:

    • Genetic testing

    • Neurological exam

    • Mini-mental state exam (MMSE)

    • Brain imaging

    • Other

    Alzheimer's Disease Diagnostic Market, By Application:

    • Clinics

    • Hospitals

    • Diagnostic Centers

    • Other

    Some of the leading players are as follows:

    • Eli Lilly

    • Accera

    • TauRx

    • Treventis

    • Alector

    • Cognition Therapeutics

    • Neuro-Bio

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Alzheimer's Disease Diagnostic Market: Technology Type Analysis

    • 4.1 Alzheimer's Disease Diagnostic Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Alzheimer's Disease Diagnostic Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Genetic testing

      • 4.3.2 Neurological exam

      • 4.3.3 Mini-mental state exam (MMSE)

      • 4.3.4 Brain imaging

      • 4.3.5 Other

    5 Alzheimer's Disease Diagnostic Market: Product Analysis

    • 5.1 Alzheimer's Disease Diagnostic Product Market Share Analysis, 2018 & 2026

    • 5.2 Alzheimer's Disease Diagnostic Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Alzheimer's Disease Diagnostic Market: Application Analysis

    • 6.1 Alzheimer's Disease Diagnostic Application Market Share Analysis, 2018 & 2026

    • 6.2 Alzheimer's Disease Diagnostic Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Clinics

      • 6.3.2 Hospitals

      • 6.3.3 Diagnostic Centers

      • 6.3.4 Other

    7 Alzheimer's Disease Diagnostic Market: Regional Analysis

    • 7.1 Alzheimer's Disease Diagnostic Regional Market Share Analysis, 2018 & 2026

    • 7.2 Alzheimer's Disease Diagnostic Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Eli Lilly

      • 9.1.1 Eli Lilly Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Accera

      • 9.2.1 Accera Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 TauRx

      • 9.3.1 TauRx Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Treventis

      • 9.4.1 Treventis Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Alector

      • 9.5.1 Alector Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Cognition Therapeutics

      • 9.6.1 Cognition Therapeutics Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Neuro-Bio

      • 9.7.1 Neuro-Bio Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

     

    The List of Tables and Figures (Totals 80 Figures and 146 Tables)

    • Figure Genetic testing Alzheimer's Disease Diagnostic market, 2015 - 2026 (USD Million)

    • Figure Neurological exam Alzheimer's Disease Diagnostic market, 2015 - 2026 (USD Million)

    • Figure Mini-mental state exam (MMSE) Alzheimer's Disease Diagnostic market, 2015 - 2026 (USD Million)

    • Figure Brain imaging Alzheimer's Disease Diagnostic market, 2015 - 2026 (USD Million)

    • Figure Other Alzheimer's Disease Diagnostic market, 2015 - 2026 (USD Million)

    • Figure Clinics market, 2015 - 2026 (USD Million)

    • Figure Hospitals market, 2015 - 2026 (USD Million)

    • Figure Diagnostic Centers market, 2015 - 2026 (USD Million)

    • Figure Other market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Alzheimer's Disease Diagnostic market, by country, 2015 - 2026 (USD Million)

    • Table North America Alzheimer's Disease Diagnostic market, by type, 2015 - 2026 (USD Million)

    • Table North America Alzheimer's Disease Diagnostic market, by product, 2015 - 2026 (USD Million)

    • Table North America Alzheimer's Disease Diagnostic market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Alzheimer's Disease Diagnostic market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Alzheimer's Disease Diagnostic market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Alzheimer's Disease Diagnostic market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Alzheimer's Disease Diagnostic market, by type, 2015 - 2026 (USD Million)

    • Table Canada Alzheimer's Disease Diagnostic market, by product, 2015 - 2026 (USD Million)

    • Table Canada Alzheimer's Disease Diagnostic market, by application, 2015 - 2026 (USD Million)

    • Table Europe Alzheimer's Disease Diagnostic market, by country, 2015 - 2026 (USD Million)

    • Table Europe Alzheimer's Disease Diagnostic market, by type, 2015 - 2026 (USD Million)

    • Table Europe Alzheimer's Disease Diagnostic market, by product, 2015 - 2026 (USD Million)

    • Table Europe Alzheimer's Disease Diagnostic market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Alzheimer's Disease Diagnostic market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Alzheimer's Disease Diagnostic market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Alzheimer's Disease Diagnostic market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Alzheimer's Disease Diagnostic market, by type, 2015 - 2026 (USD Million)

    • Table Germany Alzheimer's Disease Diagnostic market, by product, 2015 - 2026 (USD Million)

    • Table Germany Alzheimer's Disease Diagnostic market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Alzheimer's Disease Diagnostic market, by type, 2015 - 2026 (USD Million)

    • Table France Alzheimer's Disease Diagnostic market, by product, 2015 - 2026 (USD Million)

    • Table France Alzheimer's Disease Diagnostic market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Alzheimer's Disease Diagnostic market, by type, 2015 - 2026 (USD Million)

    • Table Italy Alzheimer's Disease Diagnostic market, by product, 2015 - 2026 (USD Million)

    • Table Italy Alzheimer's Disease Diagnostic market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Alzheimer's Disease Diagnostic market, by type, 2015 - 2026 (USD Million)

    • Table Spain Alzheimer's Disease Diagnostic market, by product, 2015 - 2026 (USD Million)

    • Table Spain Alzheimer's Disease Diagnostic market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Alzheimer's Disease Diagnostic market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Alzheimer's Disease Diagnostic market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Alzheimer's Disease Diagnostic market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Alzheimer's Disease Diagnostic market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Alzheimer's Disease Diagnostic market, by type, 2015 - 2026 (USD Million)

    • Table China Alzheimer's Disease Diagnostic market, by product, 2015 - 2026 (USD Million)

    • Table China Alzheimer's Disease Diagnostic market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Alzheimer's Disease Diagnostic market, by type, 2015 - 2026 (USD Million)

    • Table Japan Alzheimer's Disease Diagnostic market, by product, 2015 - 2026 (USD Million)

    • Table Japan Alzheimer's Disease Diagnostic market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Alzheimer's Disease Diagnostic market, by type, 2015 - 2026 (USD Million)

    • Table India Alzheimer's Disease Diagnostic market, by product, 2015 - 2026 (USD Million)

    • Table India Alzheimer's Disease Diagnostic market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Alzheimer's Disease Diagnostic market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Alzheimer's Disease Diagnostic market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Alzheimer's Disease Diagnostic market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Alzheimer's Disease Diagnostic market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Alzheimer's Disease Diagnostic market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Alzheimer's Disease Diagnostic market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Alzheimer's Disease Diagnostic market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Alzheimer's Disease Diagnostic market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Alzheimer's Disease Diagnostic market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Alzheimer's Disease Diagnostic market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Alzheimer's Disease Diagnostic market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Alzheimer's Disease Diagnostic market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Alzheimer's Disease Diagnostic market, by application, 2015 - 2026 (USD Million)

    • Table MEA Alzheimer's Disease Diagnostic market, by country, 2015 - 2026 (USD Million)

    • Table MEA Alzheimer's Disease Diagnostic market, by type, 2015 - 2026 (USD Million)

    • Table MEA Alzheimer's Disease Diagnostic market, by product, 2015 - 2026 (USD Million)

    • Table MEA Alzheimer's Disease Diagnostic market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Alzheimer's Disease Diagnostic market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Alzheimer's Disease Diagnostic market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Alzheimer's Disease Diagnostic market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Alzheimer's Disease Diagnostic market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Alzheimer's Disease Diagnostic market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Alzheimer's Disease Diagnostic market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Eli Lilly Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Accera Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table TauRx Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Treventis Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Alector Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Cognition Therapeutics Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Neuro-Bio Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.